MINNEAPOLIS--(BUSINESS WIRE)--Pops announces clearance from Australia�s regulatory body, the Therapeutic Goods Administration, and it�s first commercial user in Australia. Pops, a digital health company for diabetes and related chronic conditions, is already commercialized in the United States.
�We already have people in all 50 states in the U.S. using the Pops self-care platform and Mina, our virtual health assistant to change their life,� said Lonny Stormo, CEO. �It is exciting to see this unique solution now deployed in Australia.� Pops is now being deployed through a pilot with Zurich Insurance Group.
The news comes after Pops was one of the winners at the 2020 Zurich Innovation Championships - a competition held annually by Zurich Insurance Group. The competition offers start-ups the opportunity to pitch innovative ideas aimed at solving some of society�s biggest challenges and providing protection from emerging risks. The 2021 Zurich Innovation Championship has recently opened for its next round of entrants.
Pops� self-care platform is a new way to approach the high growth and cost of diabetes. Earlier this year, Pops published outcome data at the 2021 American Diabetes Association Scientific Sessions demonstrating 18-month sustained improved glucose management with the self-care platform.
About Pops
Pops has commercialized a digital health selfcare platform, starting in the diabetes space. The platform is centered around Mina, an AI Virtual Health Assistant. Mina is surrounded by a growing ecosystem of service/education/sensors/therapies including Pops� proprietary Rebel glucose meter. With Pops, it�s time to Own Your Life�. Learn more at https://popsdiabetes.com/.
Contacts
Stephanie Toomey
[email protected]
